ChemBriefRevolution Medicines Chemist Jim Cregg on Targeting Undruggable KRas
Revolution Medicines chemist Jim Cregg discusses his work targeting the undruggable KRas protein following the company's acquisition of Warp Drive Bio. His research focuses on developing small molecul
cen · 2026-05-13 00:00 UTC